Evidence map›Paper›PMID 29593534›Full record

ArticleFrontiers in pharmacology2018

East Indian Sandalwood Oil Is a Phosphodiesterase Inhibitor: A New Therapeutic Option in the Treatment of Inflammatory Skin Disease.

Manju Sharma, Corey Levenson, John C Browning, Emily M Becker, Ian Clements, Paul Castella, Michael E Cox

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. East Indian sandalwood (RSC advances · 2018
    Article
  6. Sandalwood Album Oil as a Botanical Therapeutic in Dermatology.The Journal of clinical and aesthetic dermatology · 2017
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Manju SharmaThe Vancouver Prostate Centre, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada.
Corey LevensonSantalis Pharmaceuticals, Inc., San Antonio, TX, United States.
John C BrowningTexas Dermatology and Laser Specialists, San Antonio, TX, United States.
Emily M BeckerTexas Dermatology and Laser Specialists, San Antonio, TX, United States.
Ian ClementsSantalis Pharmaceuticals, Inc., San Antonio, TX, United States.
Paul CastellaSantalis Pharmaceuticals, Inc., San Antonio, TX, United States.
Michael E CoxThe Vancouver Prostate Centre, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada.
Texas Dermatology and Laser Specialists · USVancouver Coastal Health · CAVancouver Coastal Health Research Institute · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclic adenosine monophosphate phosphodiesterases (PDEs) regulate pro-inflammatory cytokine production. One isoform, PDE4, is overactive in chronic relapsing inflammatory skin diseases: psoriasis and eczema/atopic dermatitis, and in several cancers. East Indian sandalwood oil (EISO) has significant anti-inflammatory properties. Here, we report that 75% of pediatric eczema/atopic dermatitis patients treated with topical EISO formulations achieved a >50% reduction in their Eczema Area and Severity Index score. EISO treatment of a psoriasis model reduced PDE4 expression and reversed histopathology. EISO directly inhibited PDE enzymatic activity

Indexed as

anti-inflammatoryanti-proliferativeatopic dermatitiscancereczemaphosphodiesterasepsoriasisskin organoid

Identifiers

PMID29593534
PMCPMC5854648
OpenAlexW2791770187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.